Personal Care
8 articles on Personal Care, researched and written by the Shotlee Editorial Team from primary sources.
Oral Wegovy in the UK: A New Era for Weight Management
Novo Nordisk's groundbreaking approval of an oral GLP-1 for weight management in the UK marks a significant shift, promising wider accessibility and influencing consumer markets.
6 min read
The Sweet Scent Surge: Why Gourmand Fragrances Are Back and Their GLP-1 Connection
Dive into the captivating world of gourmand fragrances, exploring their resurgence in popularity and a fascinating, unexpected connection to GLP-1 medications. Learn how these sweet scents offer a unique form of sensory indulgence.
7 min read
Beyond the Scale: Navigating Weight Loss and Appearance Concerns
Significant weight loss, often achieved with medications like GLP-1 agonists, can bring about transformative health benefits but also raises questions about changes in appearance. This article delves into the phenomenon of 'Mounjaro face,' discusses how to approach sensitive conversations about appearance with friends and family, and offers practical advice for maintaining well-being during and after weight loss.
9 min read
Survey: 3M Canadians on GLP-1 Drugs Like Ozempic, Reshaping Eating and Spending
A new Leger Healthcare survey estimates that around three million Canadian adults are currently using GLP-1 medications such as Ozempic or Mounjaro. These drugs are not only curbing appetite and cravings but also transforming daily spending habits, from less restaurant takeout to more fresh produce and gym memberships. Weight loss tops the reasons, but barriers like cost keep millions from starting.
5 min read
2026 Set to Deliver Additional GLP-1 Weight Loss Treatments – Alongside Shifting Routines. Specific Investments Ready for Gains
As obstacles to GLP-1 drug adoption diminish in 2026 with lower prices and oral options, usage is expected to surge, reshaping consumer behaviors and creating investment prospects. Market data reveals trends in treatment duration and household impacts, while analysts highlight emerging segments and company adaptations.
5 min read
Reasons for the Hype Around Wegovy -- And Its Actual Significance for Investing in Novo Nordisk
Novo Nordisk has shifted its focus with Wegovy, a groundbreaking GLP-1 injection for weight management, driving significant interest and market shifts. This article explores the drug's efficacy, market forces, and potential impacts on the company's shares. Investors should consider the opportunities and risks tied to this transformative product.
6 min read
Agrifoodtech Trends: Insights into 2026 from GLP-1s to Continuous Fermentation
As we approach 2026, agrifoodtech founders are closely monitoring significant trends. From the influence of GLP-1 drugs on consumer choices to the transformative potential of AI and continuous fermentation, these innovations are set to reshape the industry.
9 min read
Trinny Woodall's Saturday Routine: My Rest Day Involves Eating What I Want
Trinny Woodall shares her Saturday routine, emphasizing rest and indulgence. From morning supplements and walks to evening skincare and family time, discover how she balances self-care and relaxation.
4 min read